Home › Encouraging Final Data for Phase 1 Portion of Ongoing Phase 1/2 Trial with Zoptarelin Doxorubicin
 

Keywords :   


Encouraging Final Data for Phase 1 Portion of Ongoing Phase 1/2 Trial with Zoptarelin Doxorubicin

2013-06-05 01:19:14| Logistics - Topix.net

Aeterna Zentaris Inc. today announced that final data for the Phase 1 portion of the ongoing Phase 1/2 trial with its lead oncology compound, zoptarelin doxorubicin , demonstrated the compound's promising anti-tumor activity in heavily pre-treated men with castration- and taxane-resistant prostate cancer.

Tags: with data final trial

Category:Transportation and Logistics

Latest from this category

All news
16.11Tropical Storm Sara Graphics
16.11Tropical Storm Sara Wind Speed Probabilities Number 13
16.11Summary for Tropical Storm Sara (AT4/AL192024)
16.11Tropical Storm Sara Public Advisory Number 13
16.11Tropical Storm Sara Forecast Advisory Number 13
16.11Tropical Storm Sara Graphics
16.11Summary for Tropical Storm Sara (AT4/AL192024)
16.11Tropical Storm Sara Public Advisory Number 12A
Transportation and Logistics »
16.11Big - Bjarke Ingels Group
16.11
16.11PSA9 CHR PSA
16.11Nike GIANTS XXL
16.11 1
16.11 TDN-212L
16.11 EAGLE ChestRig & SAFARILAND BodyArmor
16.11foil1
More »